• Mashup Score: 2

    Increasing evidence suggests that dysregulation of cellular metabolism has a role in the pathophysiology of autosomal dominant polycystic kidney disease. Here the authors discuss the underlying pathways and review efforts to use pharmacological interventions and lifestyle modifications to slow disease progression.

    Tweet Tweets with this article
    • Model of metabolic dysfunction in #PKD from a Review by Luis Fernando Menezes and Gregory Germino https://t.co/9gGvvXEWSZ https://t.co/a3EfkDJTuA

  • Mashup Score: 7

    Autosomal dominant polycystic kidney disease (ADPKD) is caused by pathogenic mutations in the genes that encode polycystin 1 (PC1) and PC2. In this article, the authors discuss findings from structural and electrophysiological studies that give us insight into the function of polycystins and ADPKD pathogenesis.

    Tweet Tweets with this article
    • Structure and function of polycystins: insights into #PKD: a Review from Dominique Douguet, Amanda Patel & Eric Honoré https://t.co/HW2iCkrzhc https://t.co/Oz9ZgEWDO2

  • Mashup Score: 5

    Increasing evidence suggests that dysregulation of cellular metabolism has a role in the pathophysiology of autosomal dominant polycystic kidney disease. Here the authors discuss the underlying pathways and review efforts to use pharmacological interventions and lifestyle modifications to slow disease progression.

    Tweet Tweets with this article
    • Cyclic AMP signalling in polycystic kidney disease from our Review on the pathobiology of #PKD from a metabolic viewpoint by Luis Fernando Menezes & Gregory Germino https://t.co/9gGvvXWxKx https://t.co/479JA2K9u2

  • Mashup Score: 2

    Accurate prediction of risk for disease progression is crucial for clinical management of autosomal dominant polycystic kidney disease (ADPKD). The Mayo imaging classification of ADPKD uses height-adjusted total kidney volume (htTKV) and age to identify patients at highest risk. Because the current Mayo classification applies only to patients with typical diffuse cystic disease (class 1) and…

    Tweet Tweets with this article
    • In autosomal dominant polycystic #kidneydisease, excluding prominent exophytic cysts when measuring height-adjusted total #kidney volume may improve prediction of eGFR decline and allow inclusion of class 2 patients in the Mayo imaging classification https://t.co/k3YmJU2FLR #PKD https://t.co/5e5IaNiL7s